VPHIF (Valeo Pharma) Days Payable: 88.94 (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Days Payable?

Valeo Pharma VPHIF -99.00% 12 Days Payable is 88.94 as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Valeo Pharma's average Accounts Payable for the three months ended in Jul. 2024 was $6.80 Mil. Valeo Pharma's Cost of Goods Sold for the three months ended in Jul. 2024 was $6.98 Mil. Hence, Valeo Pharma's Days Payable for the three months ended in Jul. 2024 was 88.94.

The historical rank and industry rank for Valeo Pharma's Days Payable or its related term are showing as below:

VPHIF's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 90.38
* Ranked among companies with meaningful Days Payable only.

Valeo Pharma's Days Payable increased from Jul. 2023 (80.82) to Jul. 2024 (88.94). It may suggest that Valeo Pharma delayed paying its suppliers.

Valeo Pharma Days Payable Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Days Payable Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Days Payable
Get a 7-Day Free Trial 208.72 216.58 199.54 100.29 34.57

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.82 59.68 54.57 74.29 88.94

VPHIF vs ZTS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Days Payable falls into.


VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Valeo Pharma's Days Payable for the fiscal year that ended in Oct. 2023 is calculated as

Days Payable (A: Oct. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Oct. 2022 ) + Accounts Payable (A: Oct. 2023 )) / count ) / Cost of Goods Sold (A: Oct. 2023 )*Days in Period
=( (2.73 + 2.911) / 2 ) / 29.779*365
=2.8205 / 29.779*365
=34.57

Valeo Pharma's Days Payable for the quarter that ended in Jul. 2024 is calculated as:

Days Payable (Q: Jul. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Apr. 2024 ) + Accounts Payable (Q: Jul. 2024 )) / count ) / Cost of Goods Sold (Q: Jul. 2024 )*Days in Period
=( (6.243 + 7.356) / 2 ) / 6.976*365 / 4
=6.7995 / 6.976*365 / 4
=88.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 88.94 mean?
Valeo Pharma (VPHIF) has a Days Payable of 88.94 as of Jul. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Days Payable too high?
Valeo Pharma's current Days Payable is 88.94. The Drug Manufacturers industry median Days Payable is 90.38. Valeo Pharma's value of 88.94 is 1.6% below this industry median. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Days Payable compare to ZTS?
Valeo Pharma's Days Payable of 88.94 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.38. Valeo Pharma's value of 88.94 is 1.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valeo Pharma's current Days Payable of 88.94 is 1.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Valeo Pharma and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valeo Pharma's current Days Payable is 88.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Days Payable of 88.94. The current Days Payable is 88.94 and 1.6% below the Drug Manufacturers industry median of 90.38. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Days Payable is 88.94 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price